Proteomedix raises €2.9M Series B round

21 September 2021· Zurich, Switzerland· health, biotech, diagnostics, oncology, b2b, pure_software

Investors

LeadZhejiang Nuhui Health Technology

About Proteomedix

Stage
Series B
Headquarters
Zurich, Switzerland
Founded
2010
Team Size
6–20
Sectors
healthbiotechdiagnosticsoncologyb2bpure_software

Source: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmLdzQC_88TMmlj0DGiZxoQzWwdVmVJ-d-989ze82g0fModdffsRtZ_LGVQ8JhPIVz4rgHmB2wpDJDZpEEGhRDgCudNCLnRlzLNx__kHRFrJsUzrpRxgawOeE1aBFrPe5kj1IS58ZYT5NUm7YnJypIfxWNwHtusBOMoWflOEsPvvU161hQD7wohy8niL84ruROx4E=